Ziopharm
Founded in 1998, ZIOPHARM Oncology is a Boston, Massachusetts-based biotechnology company employing novel gene expression, control and cell technologies to deliver safe, effective and scalable cell-based therapies for the treatment of cancer and graft-versus-host-disease.
Last updated on
About Ziopharm
Founded
2005Estimated Revenue
$10M-$50MEmployees
11-50Category
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
325414Location
City
BostonState
MassachusettsCountry
United StatesTech Stack (48)
